E-mail a Wiley Online Library Link

Geraldine T. Petr, Laurel A. Schultheis, Kayla C. Hussey, Yan Sun, Janet M. Dubinsky, Chiye Aoki and Paul A. Rosenberg Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression European Journal of Neuroscience 38

Version of Record online: 16 APR 2013 | DOI: 10.1111/ejn.12202

Thumbnail image of graphical abstract

Excitotoxicity is thought to be important in the pathogenesis of Huntington's disease (HD). Glutamate is the predominant excitatory neurotransmitter in the brain and excess activation of glutamate receptors can cause neuronal dysfunction and death. GLT-1 is the most abundant glutamate transporter, and here we show it is expressed in both excitatory terminals and astrocytes in the striatum. Our results suggest that changes in GLT-1 expression or function per se are unlikely to potentiate or ameliorate HD progression.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field